Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription


3 Ann Intern Med
1 Antimicrob Agents Chemother
1 Biochem Soc Trans
1 BMC Pediatr
11 BMJ
1 Cell
3 Epidemiol Infect
11 J Clin Microbiol
1 J Exp Med
1 J Gen Virol
1 J Immunol
2 J Infect Dis
1 J Virol
23 J Virol Methods
5 Lancet
3 N Engl J Med
2 Pediatrics
4 PLoS Comput Biol
30 PLoS One
2 Proc Natl Acad Sci U S A
14 Vaccine

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Intern Med

  1. BARRETT E, Hingle ST, Smith CD, Moyer DV, et al
    Getting Through COVID-19: Keeping Clinicians in the Workforce.
    Ann Intern Med. 2021 Sep 28. doi: 10.7326/M21-3381.

  2. MOGHADAS SM, Sah P, Shoukat A, Meyers LA, et al
    Population Immunity Against COVID-19 in the United States.
    Ann Intern Med. 2021 Sep 14. doi: 10.7326/M21-2721.
    PubMed         Abstract available

  3. PALTIEL AD, Schwartz JL
    Assessing COVID-19 Prevention Strategies to Permit the Safe Opening of Residential Colleges in Fall 2021.
    Ann Intern Med. 2021 Aug 31. doi: 10.7326/M21-2965.
    PubMed         Abstract available

    Antimicrob Agents Chemother

  4. TIETJEN I, Cassel J, Register ET, Zhou XY, et al
    The Natural Stilbenoid (-)-Hopeaphenol Inhibits Cellular Entry of SARS-CoV-2 USA-WA1/2020, B.1.1.7, and B.1.351 Variants.
    Antimicrob Agents Chemother. 2021;65:e0077221.
    PubMed         Abstract available

    Biochem Soc Trans

  5. ZASLONA ME, Downey AM, Seeberger PH, Moscovitz O, et al
    Semi- and fully synthetic carbohydrate vaccines against pathogenic bacteria: recent developments.
    Biochem Soc Trans. 2021;49:2411-2429.
    PubMed         Abstract available

    BMC Pediatr

  6. ACEVEDO L, Pineres-Olave BE, Nino-Serna LF, Vega LM, et al
    Mortality and clinical characteristics of multisystem inflammatory syndrome in children (MIS-C) associated with covid-19 in critically ill patients: an observational multicenter study (MISCO study).
    BMC Pediatr. 2021;21:516.
    PubMed         Abstract available


    PPE: producing polluted environment.
    BMJ. 2021;375:n2822.

  8. CAAN W
    Parliamentary committee report on covid-19 response: the difference between an apology and repentance.
    BMJ. 2021;375:n2813.

  9. ALTMANN D, Boyton R
    Covid-19 caseload in the UK-assessments and mitigations.
    BMJ. 2021;375:n2843.

    Long covid: new wine in need of new bottles.
    BMJ. 2021;375:n2736.

    New Zealand's covid-19 policy switch will harm vulnerable people.
    BMJ. 2021;375:n2738.

  12. MOON J, Wenham C, Harman S
    SAGO has a politics problem, and WHO is ignoring it.
    BMJ. 2021;375:n2786.

    Encouraging covid vaccine uptake and safe behaviours-an uphill struggle against government complacency.
    BMJ. 2021;375:n2773.

  14. BHUTTA ZA, Mitra A, Salman A, Akbari F, et al
    Conflict, extremism, resilience and peace in South Asia; can covid-19 provide a bridge for peace and rapprochement?
    BMJ. 2021;375:e067384.

    Covid-19 and laws for workplace violence in healthcare.
    BMJ. 2021;375:n2776.

  16. TALIC S, Shah S, Wild H, Gasevic D, et al
    Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis.
    BMJ. 2021;375:e068302.
    PubMed         Abstract available

  17. GLASZIOU PP, Michie S, Fretheim A
    Public health measures for covid-19.
    BMJ. 2021;375:n2729.


  18. PAYNE RP, Longet S, Austin JA, Skelly DT, et al
    Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine.
    Cell. 2021;184:5699-5714.
    PubMed         Abstract available

    Epidemiol Infect

  19. BAYS D, Bennett E, Finnie T
    What effect might border screening have on preventing the importation of COVID-19 compared with other infections? A modelling study.
    Epidemiol Infect. 2021;149:e238.
    PubMed         Abstract available

  20. ABU JABAL K, Ben-Amram H, Beiruti K, Brimat I, et al
    SARS-CoV-2 immunogenicity in individuals infected before and after COVID-19 vaccination: Israel, January-March 2021.
    Epidemiol Infect. 2021;149:e239.
    PubMed         Abstract available

  21. TATSI EB, Filippatos F, Michos A
    SARS-CoV-2 variants and effectiveness of vaccines: a review of current evidence.
    Epidemiol Infect. 2021;149:e237.
    PubMed         Abstract available

    J Clin Microbiol

  22. JEONG S, Lee N, Lee SK, Cho EJ, et al
    Comparison of the Results of Five SARS-CoV-2 Antibody Assays before and after the First and Second ChAdOx1 nCoV-19 Vaccinations among Health Care Workers: a Prospective Multicenter Study.
    J Clin Microbiol. 2021;59:e0178821.
    PubMed         Abstract available

  23. BABIKER A, Immergluck K, Stampfer SD, Rao A, et al
    Single-Amplicon Multiplex Real-Time Reverse Transcription-PCR with Tiled Probes To Detect SARS-CoV-2 spike Mutations Associated with Variants of Concern.
    J Clin Microbiol. 2021;59:e0144621.
    PubMed         Abstract available

  24. KRUSE RL, Huang Y, Lee A, Zhu X, et al
    A Hemagglutination-Based Semiquantitative Test for Point-of-Care Determination of SARS-CoV-2 Antibody Levels.
    J Clin Microbiol. 2021;59:e0118621.
    PubMed         Abstract available

  25. TROBAJO-SANMARTIN C, Miqueleiz A, Portillo ME, Fernandez-Huerta M, et al
    Emergence of SARS-CoV-2 Variant B.1.575.2, Containing the E484K Mutation in the Spike Protein, in Pamplona, Spain, May to June 2021.
    J Clin Microbiol. 2021;59:e0173621.
    PubMed         Abstract available

  26. ERGUN M, Bruggemann RJM, Alanio A, Delliere S, et al
    Aspergillus test profiles and mortality in critically-ill COVID-19 patients.
    J Clin Microbiol. 2021 Sep 8:JCM0122921. doi: 10.1128/JCM.01229.
    PubMed         Abstract available

  27. LEUZINGER K, Osthoff M, Drager S, Pargger H, et al
    Comparing Immunoassays for SARS-CoV-2 Antibody Detection in Patients with and without Laboratory-Confirmed SARS-CoV-2 Infection.
    J Clin Microbiol. 2021;59:e0138121.
    PubMed         Abstract available

  28. PLITNICK J, Griesemer S, Lasek-Nesselquist E, Singh N, et al
    Whole-Genome Sequencing of SARS-CoV-2: Assessment of the Ion Torrent AmpliSeq Panel and Comparison with the Illumina MiSeq ARTIC Protocol.
    J Clin Microbiol. 2021;59:e0064921.
    PubMed         Abstract available

  29. GRAF EH
    Finding the Middle Ground with the Clinical Laboratory's Role in SARS-CoV-2 Genomic Surveillance.
    J Clin Microbiol. 2021;59:e0181621.
    PubMed         Abstract available

  30. ARMSTRONG DT, Tacheny EA, Olinger G, Howard R, et al
    SARS-CoV-2 Supply Shortages and Tuberculosis Diagnostics: Current Issues Requiring Immediate Solutions.
    J Clin Microbiol. 2021;59:e0077821.
    PubMed         Abstract available

  31. YANSON K, Laviers W, Neely L, Lockamy E, et al
    Performance Evaluation of the BD SARS-CoV-2 Reagents for the BD MAX System.
    J Clin Microbiol. 2021;59:e0101921.
    PubMed         Abstract available

  32. STOKES NL, Reed KA, Berbari EF, Vetter S, et al
    Evaluation of the BinaxNOW COVID-19 Rapid Antigen Test in an Asymptomatic Patient Population Undergoing Preprocedural Screening.
    J Clin Microbiol. 2021;59:e0165021.

    J Exp Med

  33. MAO T, Israelow B, Lucas C, Vogels CBF, et al
    A stem-loop RNA RIG-I agonist protects against acute and chronic SARS-CoV-2 infection in mice.
    J Exp Med. 2022;219.
    PubMed         Abstract available

    J Gen Virol

  34. VIANA K, Zarpelon L, Leandro A, Terencio M, et al
    Infection in asymptomatic carriers of SARS-CoV-2 can interfere with the achievement of robust immunity on a population scale.
    J Gen Virol. 2021;102.
    PubMed         Abstract available

    J Immunol

  35. HUSSAIN SA, Rohlfing M, Resiliac J, Santoro J, et al
    Atopic Neutrophils Prevent Postviral Airway Disease.
    J Immunol. 2021;207:2589-2597.
    PubMed         Abstract available

    J Infect Dis

  36. LEWIS AM, Zhang X, Brestoff JR
    Coronavirus Disease 2019 Severity in Obese Patients May Be Linked to Viral Load and Immune Response.
    J Infect Dis. 2021;224:1449-1451.

    Approaching the End of the Era of Uncontrolled Respiratory Syncytial Virus Disease.
    J Infect Dis. 2021;223:737-739.

    J Virol

  38. ZHANG H, Zheng H, Guo P, Hu L, et al
    Correction for Zhang et al., "Broadly Protective CD8(+) T Cell Immunity to Highly Conserved Epitopes Elicited by Heat Shock Protein gp96-Adjuvanted Influenza Monovalent Split Vaccine".
    J Virol. 2021;95:e0175021.

    J Virol Methods

  39. SHAH SR, Kane SR, Elsheikh M, Alfaro TM, et al
    Development of a rapid viability RT-PCR (RV-RT-PCR) method to detect infectious SARS-CoV-2 from swabs.
    J Virol Methods. 2021;297:114251.
    PubMed         Abstract available

  40. MANENTI A, Molesti E, Maggetti M, Torelli A, et al
    The theory and practice of the viral dose in neutralization assay: Insights on SARS-CoV-2 "doublethink" effect.
    J Virol Methods. 2021;297:114261.
    PubMed         Abstract available

  41. WEHRENDT DP, Masso MG, Gonzales Machuca A, Vargas CV, et al
    A rapid and simple protocol for concentration of SARS-CoV-2 from sewage.
    J Virol Methods. 2021;297:114272.
    PubMed         Abstract available

  42. RIESTER E, Findeisen P, Hegel JK, Kabesch M, et al
    Performance evaluation of the Roche Elecsys Anti-SARS-CoV-2 S immunoassay.
    J Virol Methods. 2021;297:114271.
    PubMed         Abstract available

  43. BARONTI C, Coutard B, de Lamballerie X, Charrel R, et al
    Evaluation of formulations to improve SARS-CoV-2 viability and thermostability after lyophilisation.
    J Virol Methods. 2021;297:114252.
    PubMed         Abstract available

  44. SALVO M, Moller A, Alvareda E, Gamazo P, et al
    Evaluation of low-cost viral concentration methods in wastewaters: Implications for SARS-CoV-2 pandemic surveillances.
    J Virol Methods. 2021;297:114249.
    PubMed         Abstract available

  45. BLAIRON L, Cupaiolo R, Piteus S, Beukinga I, et al
    The challenge of screening SARS-CoV-2 variants of concern with RT-qPCR: One variant can hide another.
    J Virol Methods. 2021;297:114248.
    PubMed         Abstract available

  46. CIESIELSKI M, Blackwood D, Clerkin T, Gonzalez R, et al
    Assessing sensitivity and reproducibility of RT-ddPCR and RT-qPCR for the quantification of SARS-CoV-2 in wastewater.
    J Virol Methods. 2021;297:114230.
    PubMed         Abstract available

  47. MARIEN J, Michiels J, Heyndrickx L, Nkuba-Ndaye A, et al
    Evaluation of a surrogate virus neutralization test for high-throughput serosurveillance of SARS-CoV-2.
    J Virol Methods. 2021;297:114228.
    PubMed         Abstract available

  48. VELASCO JM, Shrestha S, Valderama MT, Shrestha J, et al
    A multi-country field validation of the FluChip-8G Insight Assay.
    J Virol Methods. 2021;289:114029.
    PubMed         Abstract available

    Mouse hepatitis virus: A betacoronavirus model to study the virucidal activity of air disinfection equipment on surface contamination.
    J Virol Methods. 2021;297:114274.
    PubMed         Abstract available

  50. DI CARLO D, Mazzuti L, Sciandra I, Guerrizio G, et al
    Comparison of FTD SARS-CoV-2 Assay and RealStar RT-PCR kit 1.0 for the detection of SARS-CoV-2.
    J Virol Methods. 2021;298:114276.
    PubMed         Abstract available

  51. XIANG H, Wen X, Wen Y, Zhang H, et al
    Development and application of a visual microarray for synchronously detecting H5N1, H7N9 and H9N2 avian influenza virus RNA.
    J Virol Methods. 2021 Nov 19:114371. doi: 10.1016/j.jviromet.2021.114371.
    PubMed         Abstract available

  52. VILLOTA SD, Nipaz VE, Carrazco-Montalvo A, Hernandez S, et al
    Alternative RNA extraction-free techniques for the real-time RT-PCR detection of SARS-CoV-2 in nasopharyngeal swab and sputum samples.
    J Virol Methods. 2021;298:114302.
    PubMed         Abstract available

  53. PAUL D, Gupta A, Rooge S, Gupta E, et al
    Performance evaluation of automated chemiluminescence immunoassay based antigen detection - Moving towards more reliable ways to predict SARS-CoV-2 infection.
    J Virol Methods. 2021;298:114299.
    PubMed         Abstract available

  54. BOERS SA, Mourik BC, van Bussel MJAWM, de Brouwer CS, et al
    Increasing diagnostic possibilities using the geneLEAD VIII platform for detection of SARS-CoV-2.
    J Virol Methods. 2021;298:114291.
    PubMed         Abstract available

  55. GUPTA A, Soni A, Rooge S, Paul D, et al
    Syndromic approach to SARS-CoV-2 detection using QIAstat-Dx SARS-CoV-2 panel from clinical samples.
    J Virol Methods. 2021;298:114300.
    PubMed         Abstract available

  56. AUPAIX A, Lazarova E, Chemais M
    A brief performance evaluation and literature review of Abbott ID Now COVID-19 rapid molecular-based test.
    J Virol Methods. 2021;298:114293.
    PubMed         Abstract available

  57. KRUTTGEN A, Klingel H, Haase G, Haefner H, et al
    Evaluation of the QuantiFERON SARS-CoV-2 interferon- release assay in mRNA-1273 vaccinated health care workers.
    J Virol Methods. 2021;298:114295.
    PubMed         Abstract available

  58. MRAVINEC M, Bajc G, Butala M
    Surface plasmon resonance approach to study drug interactions with SARS-CoV-2 RNA-dependent RNA polymerase highlights treatment potential of suramin.
    J Virol Methods. 2021;298:114283.
    PubMed         Abstract available

  59. VALLEJO L, Martinez-Rodriguez M, Nieto-Bazan MJ, Delgado-Iribarren A, et al
    Comparative study of different SARS-CoV-2 diagnostic techniques.
    J Virol Methods. 2021;298:114281.
    PubMed         Abstract available

  60. KUMAR V, Ghosh K, Chandran A, Panwar S, et al
    Multicentric evaluation of a novel point of care electrochemical ELISA platform for SARS-CoV-2 specific IgG and IgM antibody assay.
    J Virol Methods. 2021;298:114275.
    PubMed         Abstract available

  61. WANG D, Wang Z, Gao Y, Wu X, et al
    Validation of the analytical performance of nine commercial RT-qPCR kits for SARS-CoV-2 detection using certified reference material.
    J Virol Methods. 2021;298:114285.
    PubMed         Abstract available


  62. MARQUEZ N, Ward JA, Parish K, Saloner B, et al
    COVID-19 Incidence and Mortality in Federal and State Prisons Compared With the US Population, April 5, 2020, to April 3, 2021.
    JAMA. 2021 Oct 6. pii: 2784944. doi: 10.1001/jama.2021.17575.

  63. SZILAGYI PG, Thomas K, Shah MD, Vizueta N, et al
    Changes in COVID-19 Vaccine Intent From April/May to June/July 2021.
    JAMA. 2021 Oct 13. pii: 2785290. doi: 10.1001/jama.2021.18761.

  64. ABBASI J
    The Flawed Science of Antibody Testing for SARS-CoV-2 Immunity.
    JAMA. 2021 Oct 21. pii: 2785530. doi: 10.1001/jama.2021.18919.

  65. MUNCH MW, Myatra SN, Vijayaraghavan BKT, Saseedharan S, et al
    Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia: The COVID STEROID 2 Randomized Trial.
    JAMA. 2021 Oct 21. pii: 2785529. doi: 10.1001/jama.2021.18295.
    PubMed         Abstract available

  66. RUBIN R
    Monoclonal Antibodies for COVID-19 Preexposure Prophylaxis Can't Come Fast Enough for Some People.
    JAMA. 2021 Oct 27. pii: 2785781. doi: 10.1001/jama.2021.19534.

  67. GRAVES JA, Baig K, Buntin M
    The Financial Effects and Consequences of COVID-19: A Gathering Storm.
    JAMA. 2021 Oct 29. pii: 2785892. doi: 10.1001/jama.2021.18863.

  68. ABBASI J
    Flu Vaccine Candidate Elicits Enhanced Immune Response.
    JAMA. 2021;326:1784.

  69. ABBASI J
    Pfizer Launches Phase 1 mRNA Flu Vaccine Trial.
    JAMA. 2021;326:1784.

  70. ABU-RADDAD LJ, Chemaitelly H, Ayoub HH, Yassine HM, et al
    Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar.
    JAMA. 2021 Nov 1. pii: 2785918. doi: 10.1001/jama.2021.19623.
    PubMed         Abstract available

  71. SAAD M, Kennedy KF, Imran H, Louis DW, et al
    Association Between COVID-19 Diagnosis and In-Hospital Mortality in Patients Hospitalized With ST-Segment Elevation Myocardial Infarction.
    JAMA. 2021 Oct 29. pii: 2785893. doi: 10.1001/jama.2021.18890.
    PubMed         Abstract available


    Australian Commission calls for overhaul of aged care.
    Lancet. 2021;397:957.

  73. KAMPF G
    COVID-19: stigmatising the unvaccinated is not justified.
    Lancet. 2021;398:1871.

  74. HUANG L, Gu X, Cao B
    Long-term effects on survivors with COVID-19 - Authors' reply.
    Lancet. 2021;398:1872-1873.

  75. YANG C, Zhao H, Tebbutt SJ
    Long-term effects on survivors with COVID-19.
    Lancet. 2021;398:1872.

  76. ZHAO YJ, Bai W, Su Z, Ng CH, et al
    Long-term effects on survivors with COVID-19.
    Lancet. 2021;398:1871-1872.

    N Engl J Med

  77. ZARYCHANSKI R, Lawler PR, Goligher E
    Therapeutic Anticoagulation with Heparin in Patients with Covid-19. Reply.
    N Engl J Med. 2021;385:2014.

  78. FERNANDES TM, McGuire WC, Morris TA
    Therapeutic Anticoagulation with Heparin in Patients with Covid-19.
    N Engl J Med. 2021;385:2013.

  79. RUBIN EJ, Baden LR, Grinsztejn B, Morrissey S, et al
    Audio Interview: Covid-19 in Brazil and New Evidence for Vaccinating Younger Children.
    N Engl J Med. 2021;385:e79.


  80. BEERS LS, Szilagyi M, Seigel WM, Davis WS, et al
    Immunizing Against Hate: Overcoming Asian American and Pacific Islander Racism.
    Pediatrics. 2021;148.

  81. KEMPER AR, Hostutler CA, Beck K, Fontanella CA, et al
    Depression and Suicide-Risk Screening Results in Pediatric Primary Care.
    Pediatrics. 2021;148.
    PubMed         Abstract available

    PLoS Comput Biol

  82. GUERSTEIN S, Romeo-Aznar V, Dekel M, Miron O, et al
    The interplay between vaccination and social distancing strategies affects COVID19 population-level outcomes.
    PLoS Comput Biol. 2021;17:e1009319.
    PubMed         Abstract available

  83. ZUVANOV L, Basso Garcia AL, Correr FH, Bizarria R Jr, et al
    The experience of teaching introductory programming skills to bioscientists in Brazil.
    PLoS Comput Biol. 2021;17:e1009534.
    PubMed         Abstract available

  84. KING SB, Singh M
    Comparative genomic analysis reveals varying levels of mammalian adaptation to coronavirus infections.
    PLoS Comput Biol. 2021;17:e1009560.
    PubMed         Abstract available

  85. WERTHEIM KY, Puniya BL, La Fleur A, Shah AR, et al
    A multi-approach and multi-scale platform to model CD4+ T cells responding to infections.
    PLoS Comput Biol. 2021;17:e1009209.
    PubMed         Abstract available

    PLoS One

  86. EJIGU BA, Asfaw MD, Cavalerie L, Abebaw T, et al
    Assessing the impact of non-pharmaceutical interventions (NPI) on the dynamics of COVID-19: A mathematical modelling study of the case of Ethiopia.
    PLoS One. 2021;16:e0259874.
    PubMed         Abstract available

  87. MIHELIC A, Jelovcan L, Prislan K
    Internal and external drivers for compliance with the COVID-19 preventive measures in Slovenia: The view from general deterrence and protection motivation.
    PLoS One. 2021;16:e0259675.
    PubMed         Abstract available

  88. TURSKA E, Stepien-Lampa N
    Well-being of Polish university students after the first year of the coronavirus pandemic: The role of core self-evaluations, social support and fear of COVID-19.
    PLoS One. 2021;16:e0259296.
    PubMed         Abstract available

  89. SERRA FE, Francisco RPV, de Rossi P, de Lourdes Brizot M, et al
    COVID-19 outcomes in hospitalized puerperal, pregnant, and neither pregnant nor puerperal women.
    PLoS One. 2021;16:e0259911.
    PubMed         Abstract available

  90. SINCLAIR DR, Maharani A, Stow D, Welsh CE, et al
    Can vaccination roll-out be more equitable if population risk is taken into account?
    PLoS One. 2021;16:e0259990.
    PubMed         Abstract available

  91. BRADFIELD Z, Wynter K, Hauck Y, Sweet L, et al
    COVID-19 vaccination perceptions and intentions of maternity care consumers and providers in Australia.
    PLoS One. 2021;16:e0260049.
    PubMed         Abstract available

  92. SNYDER RL, Anderson LE, White KA, Tavitian S, et al
    A qualitative assessment of factors affecting nursing home caregiving staff experiences during the COVID-19 pandemic.
    PLoS One. 2021;16:e0260055.
    PubMed         Abstract available

  93. LI X, English AS, Kulich SJ
    Anger among Chinese migrants amid COVID-19 discrimination: The role of host news coverage, cultural distance, and national identity.
    PLoS One. 2021;16:e0259866.
    PubMed         Abstract available

  94. CLOER C, Roudsari L, Rochelle L, Petrie T, et al
    Mesenchymal stromal cell-derived extracellular vesicles reduce lung inflammation and damage in nonclinical acute lung injury: Implications for COVID-19.
    PLoS One. 2021;16:e0259732.
    PubMed         Abstract available

  95. HORVE PF, Dietz L, Northcutt D, Stenson J, et al
    Evaluation of a bioaerosol sampler for indoor environmental surveillance of Severe Acute Respiratory Syndrome Coronavirus 2.
    PLoS One. 2021;16:e0257689.
    PubMed         Abstract available

  96. DENG H, Du J, Gao J, Wang Q, et al
    Network percolation reveals adaptive bridges of the mobility network response to COVID-19.
    PLoS One. 2021;16:e0258868.
    PubMed         Abstract available

  97. JAFAR A, Lasso A, Shorr R, Hutton B, et al
    Olfactory recovery following infection with COVID-19: A systematic review.
    PLoS One. 2021;16:e0259321.
    PubMed         Abstract available

  98. DECKER MR, Wood SN, Thiongo M, Byrne ME, et al
    Gendered health, economic, social and safety impact of COVID-19 on adolescents and young adults in Nairobi, Kenya.
    PLoS One. 2021;16:e0259583.
    PubMed         Abstract available

  99. LEULSEGED TW, Hassen IS, Maru EH, Zewsde WC, et al
    Characteristics and outcome profile of hospitalized African patients with COVID-19: The Ethiopian context.
    PLoS One. 2021;16:e0259454.
    PubMed         Abstract available

  100. CHEVALERE J, Cazenave L, Berthon M, Martinez R, et al
    Computer-assisted instruction versus inquiry-based learning: The importance of working memory capacity.
    PLoS One. 2021;16:e0259664.
    PubMed         Abstract available

  101. KUMAR NP, Padmapriyadarsini C, Rajamanickam A, Bhavani PK, et al
    BCG vaccination induces enhanced frequencies of memory T cells and altered plasma levels of common gammac cytokines in elderly individuals.
    PLoS One. 2021;16:e0258743.
    PubMed         Abstract available

  102. KATSUMATA Y, Sano M, Okawara H, Sawada T, et al
    Laminar flow ventilation system to prevent airborne infection during exercise in the COVID-19 crisis: A single-center observational study.
    PLoS One. 2021;16:e0257549.
    PubMed         Abstract available

  103. STAHL EC, Gopez AR, Tsuchida CA, Fan VB, et al
    LuNER: Multiplexed SARS-CoV-2 detection in clinical swab and wastewater samples.
    PLoS One. 2021;16:e0258263.
    PubMed         Abstract available

  104. OLIVER KH, Keeton C, Chalkley R, Bowman E, et al
    Virtual Vanderbilt Summer Science Academy highlighted the opportunity to impact early STEMM students career knowledge through narrative.
    PLoS One. 2021;16:e0258660.
    PubMed         Abstract available

  105. TOTH DJA, Beams AB, Keegan LT, Zhang Y, et al
    High variability in transmission of SARS-CoV-2 within households and implications for control.
    PLoS One. 2021;16:e0259097.
    PubMed         Abstract available

  106. STYRA R, Hawryluck L, Mc Geer A, Dimas M, et al
    Surviving SARS and living through COVID-19: Healthcare worker mental health outcomes and insights for coping.
    PLoS One. 2021;16:e0258893.
    PubMed         Abstract available

  107. GRANT BD, Anderson CE, Alonzo LF, Garing SH, et al
    A SARS-CoV-2 coronavirus nucleocapsid protein antigen-detecting lateral flow assay.
    PLoS One. 2021;16:e0258819.
    PubMed         Abstract available

  108. HUNTER-SCHLICHTING D, Kelsey KT, Demmer R, Patel M, et al
    Cytomegalovirus infection in malignant pleural mesothelioma.
    PLoS One. 2021;16:e0254136.
    PubMed         Abstract available

  109. KERIMOV D, Tamminen P, Viskari H, Lehtimaki L, et al
    Sampling site for SARS-CoV-2 RT-PCR-An intrapatient four-site comparison from Tampere, Finland.
    PLoS One. 2021;16:e0260184.
    PubMed         Abstract available

  110. CHARTIER KG, Guidry JPD, Lee CA, Buckley TD, et al
    At home and online during the early months of the COVID-19 pandemic and the relationship to alcohol consumption in a national sample of U.S. adults.
    PLoS One. 2021;16:e0259947.
    PubMed         Abstract available

  111. BRUBAKER J, Kilic T, Wollburg P
    Representativeness of individual-level data in COVID-19 phone surveys: Findings from Sub-Saharan Africa.
    PLoS One. 2021;16:e0258877.
    PubMed         Abstract available

  112. SCHNEIDER CR, Freeman ALJ, Spiegelhalter D, van der Linden S, et al
    The effects of quality of evidence communication on perception of public health information about COVID-19: Two randomised controlled trials.
    PLoS One. 2021;16:e0259048.
    PubMed         Abstract available

  113. JIANG Y, Duffy F, Hadlock J, Raappana A, et al
    Angiotensin II receptor I auto-antibodies following SARS-CoV-2 infection.
    PLoS One. 2021;16:e0259902.
    PubMed         Abstract available

  114. LOPES-JUNIOR LC, Siqueira PC, Maciel ELN
    School reopening and risks accelerating the COVID-19 pandemic: A systematic review and meta-analysis protocol.
    PLoS One. 2021;16:e0260189.
    PubMed         Abstract available

  115. LUCCHINI M, Gerosa T, Pancheva M, Pisati M, et al
    Differential effects of COVID-19 and containment measures on mental health: Evidence from ITA.LI-Italian Lives, the Italian household panel.
    PLoS One. 2021;16:e0259989.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  116. BALISTRERI G, Yamauchi Y, Teesalu T
    A widespread viral entry mechanism: The C-end Rule motif-neuropilin receptor interaction.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  117. LOPEZ N, Del Debbio L, Baaden M, Praprotnik M, et al
    Lessons learned from urgent computing in Europe: Tackling the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available


  118. FAN S, Li D, Zhao H, Yu L, et al
    Ameliorated immunity elicited by intradermal inoculation in individuals vaccinated with inactivated SARS-CoV-2 vaccine.
    Vaccine. 2021 Oct 22. pii: S0264-410X(21)01375.
    PubMed         Abstract available

  119. GARCIA-GRIMSHAW M, Ceballos-Liceaga SE, Michel-Chavez A, Garcia-Alanis M, et al
    Transient sensory symptoms among first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine: A case-control study.
    Vaccine. 2021 Oct 29. pii: S0264-410X(21)01391.
    PubMed         Abstract available

  120. MUSCATELLO DJ, Nazareno AL, Turner RM, Newall AT, et al
    Influenza-associated mortality in Australia, 2010 through 2019: High modelled estimates in 2017.
    Vaccine. 2021 Nov 19. pii: S0264-410X(21)01464.
    PubMed         Abstract available

  121. ORTEGA-SANCHEZ IR, Mott JA, Kittikraisak W, Khanthamaly V, et al
    Cost-effectiveness of seasonal influenza vaccination in pregnant women, healthcare workers and adults >= 60 years of age in Lao People's Democratic Republic.
    Vaccine. 2021 Nov 18. pii: S0264-410X(21)01445.
    PubMed         Abstract available

  122. IRVING SA, Ball SW, Booth SM, Regan AK, et al
    A multi-country investigation of influenza vaccine coverage in pregnant individuals, 2010-2016.
    Vaccine. 2021 Nov 18. pii: S0264-410X(21)01463.
    PubMed         Abstract available

  123. KHOURY J, Najjar-Debbiny R, Hanna A, Jabbour A, et al
    COVID-19 vaccine - Long term immune decline and breakthrough infections.
    Vaccine. 2021 Oct 30. pii: S0264-410X(21)01370.
    PubMed         Abstract available

  124. CHAPIN-BARDALES J, Myers T, Gee J, Shay DK, et al
    Reactogenicity within 2 weeks after mRNA COVID-19 vaccines: Findings from the CDC v-safe surveillance system.
    Vaccine. 2021 Oct 16. pii: S0264-410X(21)01339.
    PubMed         Abstract available

  125. GORDON SF, Clothier HJ, Morgan H, Buttery JP, et al
    Immune thrombocytopenia following immunisation with Vaxzevria ChadOx1-S (AstraZeneca) vaccine, Victoria, Australia.
    Vaccine. 2021 Oct 29. pii: S0264-410X(21)01350.
    PubMed         Abstract available

  126. MAKOVITZKI A, Lerer E, Kafri Y, Adar Y, et al
    Evaluation of a downstream process for the recovery and concentration of a Cell-Culture-Derived rVSV-Spike COVID-19 vaccine candidate.
    Vaccine. 2021 Oct 22. pii: S0264-410X(21)01376.
    PubMed         Abstract available

  127. OLANIPEKUN T, Abe T, Effoe V, Westney G, et al
    Changes in COVID-19 vaccine acceptance rate among recovered critically Ill patients: A 12-month follow-up study.
    Vaccine. 2021 Oct 25. pii: S0264-410X(21)01324.
    PubMed         Abstract available

  128. LIU H, Zhou C, An J, Song Y, et al
    Development of recombinant COVID-19 vaccine based on CHO-produced, prefusion spike trimer and alum/CpG adjuvants.
    Vaccine. 2021 Oct 30. pii: S0264-410X(21)01399.
    PubMed         Abstract available

  129. BYRNE T, Patel P, Shrotri M, Beale S, et al
    Trends, patterns and psychological influences on COVID-19 vaccination intention: Findings from a large prospective community cohort study in England and Wales (Virus Watch).
    Vaccine. 2021 Oct 8. pii: S0264-410X(21)01281.
    PubMed         Abstract available

  130. MALTEZOU HC, Panagopoulos P, Sourri F, Giannouchos TV, et al
    COVID-19 vaccination significantly reduces morbidity and absenteeism among healthcare personnel: A prospective multicenter study.
    Vaccine. 2021 Oct 30. pii: S0264-410X(21)01387.
    PubMed         Abstract available

  131. CASSONE A, Cauda R
    Multicomponent vaccines to fight SARS-CoV-2 variants of concern.
    Vaccine. 2021 Nov 1. pii: S0264-410X(21)01402.

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.